Variability in engraftment potential of different peripheral blood stem cell preparations given after cyclophosphamide, thiotepa, and carboplatin for stage II/III breast cancer.

被引：0
|
作者：
Elfenbein, G [1 ]
Perkins, J [1 ]
Janssen, W [1 ]
Fields, K [1 ]
机构：
[1] H LEE MOFFITT CANC CTR,DIV BONE MARROW TRANSPLANTAT,TAMPA,FL
来源：
EXPERIMENTAL HEMATOLOGY | 1996年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 48 条
  • [41] PERIPHERAL-BLOOD STEM-CELL COLLECTIONS AFTER PACLITAXEL, CYCLOPHOSPHAMIDE, AND RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH BREAST AND OVARIAN-CANCER
    DEMIRER, T
    ROWLEY, S
    BUCKNER, CD
    APPELBAUM, FR
    LILLEBY, K
    STORB, R
    SCHIFFMAN, K
    BENSINGER, WI
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1714 - 1719
  • [42] High-dose dense chemotherapy with epirubicin and paclitaxel with peripheral blood progenitor cell support in women with high-risk stage II-IIIA breast cancer.
    Rosti, G
    De Giorgi, U
    Frassineti, GL
    Ciucci, G
    Spinolo, L
    Flamini, E
    Giovannini, N
    Monti, M
    Zumaglini, F
    Marangolo, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 78S - 78S
  • [43] Low-dose metronomic cyclophosphamide/methotrexate (LDCM) and aspirin for patients who fail to achieve pathologic complete response (pCR) after neoadjuvant treatment for stage II-III breast cancer.
    Burdette-Radoux, Susan
    Holmes, Chris E.
    Khan, Farrah B.
    Dittus, Kim
    Wilson, Karen M.
    Wood, Marie E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Double peripheral blood stem cell transplant (PBSCT) after high dose chemotherapy (HDC) in metastatic breast cancer(MBS): Updated results of a "GOCAM" Phase II study
    Palazzo, S
    Morabito, F
    Pucci, G
    Console, G
    Cicero, G
    Serrano, P
    Liguori, V
    Lazzaro, B
    Mastroianni, CM
    Martino, M
    Filippelli, G
    Messina, G
    Irrera, G
    Iacopino, P
    ANNALS OF ONCOLOGY, 1998, 9 : 28 - 28
  • [45] Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment
    Klumpp, TR
    Goldberg, SL
    Magdalinski, AJ
    Mangan, KF
    BONE MARROW TRANSPLANTATION, 1997, 20 (04) : 273 - 281
  • [46] Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment
    TR Klumpp
    SL Goldberg
    AJ Magdalinski
    KF Mangan
    Bone Marrow Transplantation, 1997, 20 : 273 - 281
  • [47] High-dose chemotherapy (HDC) and peripheral stem-cell support in stage II–III breast cancer with extensive axillary–node involvement. Results of the treatment in 77 consecutive patients (pt)
    不详
    Bone Marrow Transplantation, 2000, 26 (Suppl 1) : S32 - S40
  • [48] The clinical significance of tumour cells in bone marrow or apheresis product and the efficacy of purging in stage III breast cancer patients who underwent high-dose chemotherapy and autologous peripheral blood stem cell transplantation
    Arpaci, F.
    Ozturk, M.
    Safali, M.
    Ural, A.
    Ozet, A.
    Cetin, T.
    Komurcu, S.
    Ozturk, B.
    Ataergin, S.
    Kuzhan, O.
    Kilic, S.
    Uncu, D.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S443 - S444
12345